New York, Sept.26 : In an historic effort to cut maternal and child deaths, a global coalition of governments and organizations will launch a major advocacy drive today entitled Deliver Now for Women + Children.

The launch will take place at public rallies in the city center and the Bronx. Women leaders of the United Nations will also hold a special discussion Saving 77 Million by 2015: Advancing the Health of Women and Children.

Washington, Sept 26 : Researchers at the Swedish medical university Karolinska Institutet (KI) and the Swedish Institute for Infectious Disease Control (SMI) say that they have identified specific parts of the adhesive protein produced by the malaria parasite, which can lead to the development of a vaccine for the disease in future.

Led by Professor Mats Wahlgren at the Department of Microbiology, Tumour and Cell Biology at KI, a team of researchers studied the adhesive protein PfEMP1 in children with severe malaria.

Washington, Sept 26 A new study has found that eating fruits and vegetables has no strong association with decreased colon cancer risk.

Several studies have examined the relationship between colon cancer and fruit and vegetable intake, but the results have not been consistent.

Washington, Sept 26 : A new research has revealed that Human Papillomavirus (HPV), a sexually transmitted disease, may cause bladder cancer.

HPV is considered the cause of one of the most important sexually transmitted diseases nowadays, and affects both men and women.

London, Sept 26 : A new study has revealed that women with advanced breast cancer can live longer by taking the drug Herceptin, even after they have suffered a relapse.

The finding is based on data from the Hermine trial, an observational study involving 340 women with advanced HER2-positive breast cancer.

Herceptin is the only HER2-targeted therapy proven to extend lives in both early and advanced stages of the disease.

Washington, Sept 26 : According to a study focused on non-mass enhancing breast lesions, Proton magnetic resonance spectroscopy (¹H MRS) used in conjunction with magnetic resonance imaging (MRI) can aid radiologists in diagnosing breast cancer while reducing the number of false-positive results and invasive biopsies.

The study, conducted at Memorial Sloan-Kettering Cancer Centre in New York, is published in the October issue of the journal Radiology.